Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Science Translational Medicine|January 21, 2021
ACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinomaPrateek Khanna, Hong Jie Soh, Chun-Hau Chen, et al.
Biorxiv : the Preprint Server for Biology|August 16, 2024
TFE3 fusions direct an oncogenic transcriptional program that drives OXPHOS and unveils vulnerabilities in translocation renal cell carcinomaJiao Li, Kaimeng Huang, Fiona McBride, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Phenotypic screening converges on CDK9 inhibition as a therapeutic strategy in translocation renal cell carcinomaDharma R Thapa, Riva Deodhar, Adam Skepner, et al.
Nature Metabolism|February 6, 2025
Oncogenic TFE3 fusions drive OXPHOS and confer metabolic vulnerabilities in translocation renal cell carcinomaJiao Li, Kaimeng Huang, Meha Thakur, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Detection and monitoring of translocation renal cell carcinoma via plasma cell-free epigenomic profilingSimon Garinet, Karl Semaan, Jiao Li, et al.
The Journal of Clinical Investigation|February 2, 2026
Cell-free DNA epigenomic profiling enables noninvasive detection and monitoring of translocation renal cell carcinomaSimon Garinet, Karl Semaan, Jiao Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2018
KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case-Control StudyGhislaine Scelo, David C Muller, Elio Riboli, et al.
Pageof 2